Additional populations comprise specialized anti-adipogenic, profibrotic, inflammatory, and fibroblast-like ASPCs
The current study Study author Yuya Koide and his colleagues wanted to explore how individuals with type 2 diabetes respond to GLP-1RAs therapy (Koide et al., 2025)
FDA-approved GLP-1 medications like semaglutide (Ozempic, Wegovy) are structurally modified to resist breakdown, have half-lives of days rather than minutes, and produce sustained receptor activation that results in greater glucose-lowering effects and clinically significant weight loss
GLP-1 Medication Titration: When to Increase and When to Stay at Your Current Dose Lori Fauquier, APN-C, WHNP Feb 6, 2025 3 min read Updated: Jun 7, 2025 GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have revolutionized medical weight loss, helping individuals control cravings, regulate blood sugar, and achieve sustainable weight loss